A Rapid Strategy for Repurposing Drugs for COVID-19

被引：0
|
作者：
Khoubnasabjafari, Maryam [1 ,2 ,3 ]
Amanlou, Massoud [4 ,5 ]
Dehpour, Ahmad Reza [5 ,6 ]
Jouyban, Abolghasem [2 ,3 ,7 ]
机构：
[1] Tabriz Univ Med Sci, TB & Lung Dis Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Pharmaceut Anal Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Fac Pharm, Tabriz, Iran
[4] Univ Tehran Med Sci, Inst Pharmaceut Sci TIPS, Drug Design & Dev Res Ctr, Tehran, Iran
[5] Univ Tehran Med Sci, Expt Med Res Ctr, Tehran, Iran
[6] Univ Tehran Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran
[7] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
来源：
PHARMACEUTICAL SCIENCES | 2020年 / 26卷
关键词：
D O I：
10.34172/PS.2020.76
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S91 / S93
页数：3
相关论文
共 50 条
  • [31] Repurposing of drugs for COVID-19: a systematic review and meta-analysis
    Kotecha, Pinky
    Light, Alexander
    Checcucci, Enrico
    Amparore, Daniele
    Fiori, Cristian
    Porpiglia, Francesco
    Dasgupta, Prokar
    Elhage, Oussama
    PANMINERVA MEDICA, 2022, 64 (01) : 96 - 114
  • [32] Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review
    Andrade, Bruno Silva
    Rangel, Fernanda de Souza
    Santos, Naiane Oliveira
    Freitas, Andria dos Santos
    de Assis Soares, Wagner Rodrigues
    Siqueira, Sergio
    Barh, Debmalya
    Goes-Neto, Aristoteles
    Birbrair, Alexander
    de Carvalho Azevedo, Vasco Ariston
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [33] A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges
    Md. Shafiul Hossen
    Md Abdul Barek
    Nusrat Jahan
    Mohammad Safiqul Islam
    SN Comprehensive Clinical Medicine, 2020, 2 (10) : 1777 - 1789
  • [34] COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
    Tufan, Abdurrahman
    Avanoglu Guler, Aslihan
    Matucci-Cerinic, Marco
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 : 620 - 632
  • [35] A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics
    Wattanakul, Thanaporn
    Chotsiri, Palang
    Scandale, Ivan
    Hoglund, Richard M.
    Tarning, Joel
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (08) : 945 - 958
  • [36] Repurposing of known drugs for COVID-19 using molecular docking and simulation analysis
    Bhanu, Piyush
    Setlur, Anagha S.
    Chandrashekar, K.
    Niranjan, Vidya
    Kumar, Nisha Hemandhar
    Buchke, Sakshi
    Kumar, Jitendra
    Rani, Anita
    Tiwari, Sushil M.
    Mishra, Vachaspati
    BIOINFORMATION, 2023, 19 (02) : 149 - 159
  • [37] A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives
    Abas Sezer
    Mervisa Halilović-Alihodžić
    Annissa Rachel Vanwieren
    Adna Smajkan
    Amina Karić
    Husein Djedović
    Jasmin Šutković
    Journal of Genetic Engineering and Biotechnology, 20
  • [38] Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
    Norinder, Ulf
    Tuck, Astrud
    Norgren, Kalle
    Kos, Vesna Munic
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
  • [39] Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses
    Li, Guobing
    Ruan, Shasha
    Zhao, Xiaolu
    Liu, Qi
    Dou, Yali
    Mao, Fengbiao
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 1 - 15
  • [40] Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19)
    Wietzikoski Lovato, Evellyn Claudia
    Barboza, Lorena Neris
    Wietzikoski, Samantha
    Vasques de Souza, Amanda Nascimento
    Auth, Pablo Alvarez
    Gasparotto Junior, Arquimedes
    dos Reis Livero, Francislaine Aparecida
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (01) : 115 - 126
12345